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Objectives: Osteoarthritis (OA) is characterized by a progressive alteration of the biochemical properties
of the articular cartilage. Inﬂammation plays a major role in OA, particularly through the cytokine
Interleukine-1b, promoting reactive oxygen species (ROS) generation and matrix metalloproteinases
(MMP) synthesis by the chondrocytes, orchestrating matrix proteolysis. NADPH oxidases (NOX) are
membrane enzymes dedicated to the production of ROS. Role of oxidative stress is well established in
OA; however, contribution of NOX in this process is still poorly documented. In this study, we addressed
the role of NOX in primary human articular chondrocytes (HAC) upon inﬂammatory conditions e namely
IL-1b and OA.
Design: HAC were collected from patients undergoing hip surgery. Chondrocytes were treated with IL-1b
and NOX inhibitors Diphenylene Iodonium, GKT136901, Tiron and Heme oxygenase-1 before MMP
expression and NOX activity assessment. Finally, NOX4 expression was compared between OA and non
OA parts of hip cartilage (n ¼ 14).
Results: This study establishes for the ﬁrst time in human that NOX4 is the main NOX isoform expressed
in chondrocytes. We found a signiﬁcant upregulation of NOX4 mRNA in OA chondrocytes. Expression of
NOX4/p22phox as well as ROS production is enhanced by IL-1b. On the other hand, the use of NOX4
inhibitors decreased IL-1b-induced collagenase synthesis by chondrocytes. Moreover, our study support
the existence of a redox dependant loop sustaining pro-catabolic pathways induced by IL-1b.
Conclusions: This study points out NOX4 as a new putative target in OA and suggests that NOX-targeted
therapies could be of interest for the causal treatment of the pathology.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
ROS are small reactive molecules derived from molecular oxy-
gen involved in physiological processes such as innate immunity
and cell signalling pathways controlling differentiation, adhesion,
migration or apoptosis1. Impairment of ROS homeostasis has been
associated with pathological states such as cell tumoralB. Lardy, AGIM e Laboratoire
uis du Gresivaudan, 38700 la
.
ternational. Published by Elsevier Ltransformation, ﬁbrosis, osteoporosis or diabetes due to inappro-
priate cell signalling. ROS production has been suggested to be part
on the ageing process2. Indeed, most of the common ageing related
degenerative pathologies such as Parkinson's disease, Alzheimer,
cancer, osteoporosis or osteoarthritis are linked to oxidative
stress1,3.
NOX family are transmembrane proteins composed of seven
members sharing speciﬁc structural homology regions4,5. NOX ca-
talyses the transfer of electron from NADPH across biological
membranes via two heme molecules to generate superoxide anion,
giving rise to ROS6. NOX4 represents the major source of ROS in
kidney and is widely expressed inmany others tissues including thetd. All rights reserved.
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through a mutual stabilization of the two partners at the protein
level11. NOX4 activity has recently been shown to be upregulated by
quinone compounds in vitro12. On the other hand, we recently
showed that NOX4 activity is negatively regulated by Heme
Oxygenase-1 (HO-1), the rate limiting enzyme in heme
catabolism13.
Osteoarthritis (OA) is a common ageing feature related to
degenerative disease inwhich chondrocytes play a central role14. In
OA, chondrocytes exhibit reticular and oxidative stress markers,
lack of proteasome recycling and a decreased mitochondria
dependent ATP generation that are common features of degener-
ative diseases15,16. In OA, chondrocytes fail to maintain homeostasis
between anabolic and catabolic pathways. IL-1b is one of the main
catabolic factors involved in osteoarthritis and many of its biolog-
ical effects are mediated through a generation of ROS17,18. For
example, in bovine chondrocytes, both IL-1b and hydrogen
peroxide led to an activation of the redox dependant transcription
factors NF-KB and AP-119 triggering a dramatic decrease in type II
collagen transcription associated with a signiﬁcant increase of
MMP synthesis.
Only few studies have addressed the role of NOX enzymes in
chondrocytes18,20,21. To our knowledge, all published studies were
performed on cell lines or in chondrocytes explants from animal
models; however, no data concerning the role of NOX in human
articular chondrocytes and in OA are presently available. In the
human C-20/A4 chondrocyte cell line NOX4 is the sole active iso-
form of NOX and its activity has been shown to mediate MMP-1
synthesis and chondrocyte apoptosis under IL-1b cytokinic stimu-
lation13,18. Interestingly, NOX4 inhibition by HO-1, prevent IL-1b-
induced MMP-1 secretion and chondrocyte apoptosis. Given the
well-known role of oxidative stress in osteoarthritis and our pre-
vious data from the chondrocyte cell line C-20/A413, we decided to
investigate the role of NOX in human articular chondrocytes and in
OA condition.
In this study, we show that NOX4 expression is the highest
among other NOX isoforms in HAC and exhibits a constitutive ox-
idase activity. Similar to chondrocytes cell line, IL-1b drives colla-
genase synthesis by HAC through an increase of NOX4 and p22phox
expression as well as ROS production. Moreover, our results point
out the existence of an autocrine/paracrine loop in which ROS
mediate IL-1b and p22phox neosynthesis, sustaining catabolic
pathways. Interestingly, IL-1b-induced ROS production is pre-
vented by the NADPH oxidase inhibitors Diphenylene Iodonium
(DPI) as well as by the use of GKT136901, a speciﬁc inhibitor of
NOX4, and by the induction of HO-1 expression in HAC. These re-
sults suggest that targeting ROS generators and in particular the
NOX4 pathway in HAC may have a promising potential for thera-
peutic strategy in the pathology of OA.
Material and methods
Material
Chemical reagents used in this study and their sources were the
following: Dulbecco's modiﬁed Eagle's medium (DMEM), fetal
bovine serum (FBS) (life technologies, Saint Aubin, France); AMV
Reverse transcriptase (QBiogene, Illkirch, France); TRIzol® reagent,
Taq polymerase, Alexa Fluor 546 or 633 labelled goat anti-mouse
IgG, Hoechst 33258, (Invitrogen, Cergy Pontoise, France); ECL
Western Blotting detection reagents, Goat anti-Mouse IgG-HRP
antibody and IL-1b ELISA detection kit (GE healthcare, Buck-
ingamshire, UK); Na4P2O7, Na3VO4, PMSF, luminol, Horseradish
Peroxidase (HRPO), Triton X-100, protoporphyrin-IX cobalt chloride
(CoPP-IX), Diphenylene iodonium (DPI), Collagenase type IA andHyaluronidase (SIGMA, Saint Quentin Fallavier, France);
GKT136901 (GenKyoTex, Plan les Ouates, Switzerland); Okadaic
acid, leupeptin, pepstatin, trypsin inhibitor, TLCK, human inter-
leukin-1b, complete mini EDTA-free protease inhibitor EASYpack
(Roche diagnostics, Meylan, France); diisopropylﬂuorophosphate
(DFP, Acros Organics, Halluin, France); polyclonal IgG from goat
against HMOX1 (sc-7695) or against actin (sc-1615) and control Ig
(Santa Cruz Biotechnologies, Heidelberg, Germany); Lab-Tek
chambered coverglass (Thermo scientiﬁc, Courtaboeuf, France);
100 mm nylon cell strainer (BD Falcon, Pont de Claix, France);
Decalciﬁer solution for histology SAKURA TDE 30 (Bayer Health-
care, Newbury, UK), second antibody anti mouse conjugated to
peroxidase (DAKO, Courtaboeuf, France); anti-MMP-1 (mAb 901)
and anti-MMP-13 monoclonal antibody (R&D Systems, Lille,
France); and Rabbit monoclonal Ig against NOX4 (UOTR1B492;
Abcam, Paris, France); NOX4 monoclonal antibody (8E9)22, p22phox
monoclonal antibody23.
Chondrocyte isolation and culture
Cartilage specimens were obtained from 14 patients aged from
46 to 90, undergoing femoral hip replacement. Samples were ob-
tained under patient's consent according to the declaration of
Helsinki. Cartilage slices were removed from the femoral head and
cut into small pieces. The distinction between the “OA chon-
drocyte” group and the control chondrocytes was determined by
pathologists, according to the OARSI guidelines24. Chondrocytes
were then isolated by sequential enzymatic digestion: 1 h with
0.1 mg/ml hyaluronidase in sterile PBS at 37C, followed by 16 h
with 1 mg/ml collagenase (type IA) at 37C in DMEM containing
10% FBS in presence of penicillin (100 U/ml) and streptomycin
(100 g/ml) at 37C in 5% CO2 atmosphere. The digested tissue was
ﬁltered through a 100 mmnylonmesh, washed and centrifuged. The
isolated chondrocytes were ﬁnally seeded in 6-well plates until
they reach conﬂuence and cultured in DMEM containing 4.5 g/L
glucose and 0.11 g/L sodium pyruvate, supplemented with 10% (v/v)
fetal bovine serum, 100 units/ml penicillin, 100 mg/ml strepto-
mycin and 2 mM glutamine at 37C, 5% CO2. For experiments with
IL-1b, cell culture medium was replaced by serum free DMEM for
24 h. Chondrocytes were then stimulated by IL-1b, supplemented
or not with antioxidants or inhibitors during 24 h. To avoid chon-
drocyte dedifferentiation, MMP-1 and MMP-13 Western Blot (WB)
and real-time quantitative (RT-q-)PCR were performed before the
ﬁrst passage; other experiments were performed after a single
passage (75 cm2 ﬂask). Collagen type II expression, a marker of
chondrocyte differentiation was checked after the ﬁrst passage
before launching chemical treatments.
RNA extraction and RT-q-PCR
Total RNA extraction was performed with NucleoSpin® RNA
(Macherey Nagel, Hoerd, France) following recommendations.
cDNA was reverse transcribed from 1 mg of total RNA with the
SuperScriptIII First-Strand Synthesis (Life Technologies, Carlsbad,
CA). As recommended an RNase H treatment was added. Real time
RT-qPCR was conducted using the QuantiTect SYBR Green RT-PCR
kit (Qiagen) and a Stratagene Mx3005P (La Jolla, CA).
Brieﬂy, the transcript expression levels of human IL-1b, CYBA,
NOX4, HMOX1, MMP-1, MMP-13, ADAMTS4 and housekeeping
genes GAPDH, RPL27 and RPL32 were determined using speciﬁc
primers chosen to include intron spanning (Supplementary Table I).
Gene expression was quantiﬁed using the comparative threshold
cycle (Ct) method. The amount of target gene, normalized to three
endogenous reference genes (RPL27, RPL32 and GAPDH) was
expressed relative to the control cells. The speciﬁcity of the PCR
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melting curve analysis.
Evaluation of ROS production by Amplex Red assay
After the ﬁrst passage chondrocytes were grown in a 75 cm2
ﬂask at 90% conﬂuence. After 24 h serum starvation, cells were
stimulated with 2 ng/ml IL-1b in presence or not of inhibitors (CoPP
or DPI 10 mM). Cells were then detached with 0.25% (w/v) trypsin,
washed twice with PBS and collected after 8 min centrifugation at
400 g at room temperature. The viability of the suspended cells was
over 95%, as determined by the trypan blue exclusion method. In a
96-well plate, 5  105 living cells resuspended in 20 ml PBS were
added per well. Before the start of the assay, 100 ml of a PBS solution
containing 5 mM Amplex Red and 10 mUnits/ml horseradish
peroxidase was added in each well. Results are expressed as the
sum of Relative Fluorescent Units (RFU) recorded every two mi-
nutes during 60 min on a ﬂuostar omega spectroﬂuorimeter (BMG
labtech).
Cell extracts preparation
Cells were treated with 3mMDFP and lysed in Triton X-100 lysis
buffer containing 20 mM TriseHCl pH 7.4, 1% (v/v) Triton X-100,
150 mM NaCl, 1 mM EDTA, 10 mM Na4P2O7, 10 nM okadaic acid,
2mMNa3VO4, 2mg/ml leupeptin, 2mg/mlpepstatin,10mg/ml trypsin
inhibitor, 44 mg/ml PMSF, 10 mM TLCK and complete mini EDTA-free
protease inhibitor (Triton X-100 cell extract). After 10 min incuba-
tion on ice, the mixture was centrifuged at 1000 g, 10 min, 4C. The
supernatant was then used for SDS-PAGE and Western Blot.
SDS/PAGE and WB
Triton X-100 cell extract 10 concentrated cell culture super-
natant were denatured at 60C for 30 min or 4C overnight and
loaded on 10% (p/v) SDS-PAGE for migration and then electro-
transfer to nitrocellulose. Immunodetection was performed using
antibodies raised against NOX4 (mAb 8E9, 1:500 or UOTR
1:2000)22, p22phox (mAb) MMP-1 (1:500), MMP-13 (1:1000); HO-1
(1:500), or Actin (1:1000). Secondary antibody was conjugated to
peroxidase (1:5000). Peroxidase activity was detected using ECL
reagents (GE Healthcare, Freiburg).
IL-1b assay
C-20/A4 chondrocytes were treated with IL-1b in a 75 cm2 ﬂask
containing serum free DMEM medium in presence or not of 10 mM
CoPP to induce HO-1 expression or with 5 mM Tiron. 24 h later, 3
washes were performed with 1X PBS. Last wash was kept to assess
residual IL-1b remaining in the ﬂask. Mediumwas then replaced by
serum free DMEMmedium for additional 24 h andwas up taken for
IL-1b neosynthesis measurement with a commercial ELISA assay.
Results are representative of three independent experiments.
Confocal microscopy
Chondrocytes were seeded on coverslips at 60% conﬂuency and
ﬁxed with 4% (w/v) paraformaldehyde (PFA) for 10 min, PFA ﬂuores-
cencewasquenchedby50mMNH4Cl for 10 additionalmin at RT. Cells
were thenwashed twice with PBS containing 1% (w/v) BSA (PBS/BSA
buffer) and permeabilizedwith 0.1% (v/v) Triton X-100 during 10min
at RT. NOX4 subcellular localizationwas assessed by 1 h incubation at
room temperaturewith 5 mg of mousemonoclonal Ig (irrelevant Ig or
8E9mAb) in 200 ml of PBS/BSA buffer. After twowasheswith PBS/BSA
buffer, 1 h incubation with anti-mouse secondary antibodiesconjugated toAlexa 546 (1/200)wasperformed at RT. Cell nucleiwere
stained with Hoechst 33258 (0.5 mg/ml) and mounted in DABCO so-
lution; they were sealed, and stored at 4C in the dark. Confocal mi-
croscopy was carried out by using the Zeiss LSM510 NLO META. The
pinhole was adjusted to 1 Airy unit resulting in 0.7 mm thick slices.
Hoechst ﬂuorescence was visualized using a 2photon excitation.
Immunohistochemistry
Human cartilage was decalciﬁed (Decalciﬁer SAKURA TDE 30,
Bayer-Tissue teck), rinsed in distilled water and embedded in
parafﬁn. 4 mm sections were then layered on polylysine coated
slides and deparafﬁned with xylene treatment. Slides where then
incubated for 40 min at 98C in EDTA solution pH8 to unmask
antigen, treated with hydrogen peroxide 3% for 10 min to inhibit
endogenous peroxidases and were incubated over night with NOX4
8E9 mAb (1/1250), 4C. After 3 rinses in PBS 1, slides were incu-
bated for 45 min with second antibody conjugated to peroxidase
before revelation. Nucleus was stained by hematoxilin and samples
were mounted on coverslips.
Statistical data
All quantitative data were generated using biological replicates
in triplicate unless stated otherwise, and are expressed as the mean
plus 95% conﬁdence interval. Data normality was tested by a Sha-
piroeWilk test. For each experiment, P-values were determined
using a paired Student test. All analyses were conducted using
StatView (SAS institute, US).
Results
NOX4 is highly expressed in human articular cartilage
IL-1b is one of themain catabolic factors involved in OA and lead
to generation of ROS by chondrocytes17,18. NOX family dedicated to
the ROS production may play a major role in response to the
cytokine. To conﬁrm this hypothesis, human articular chondrocytes
(HAC) were isolated and cultured from human femoral head ac-
cording to the Material and Method section. The mRNA expression
of NADPH oxidases (NOX1 to NOX5) and their partner p22phox was
evaluated by RT-PCR [Fig. 1(A)]. Consistent to our previous data
from the human chondrocyte cell line C-20/A418, a robust mRNA
expression of NOX4 and p22phox was shown in human primary
chondrocyte. In contrast, the other NOXs mRNA was below detec-
tion thresholds pointing NOX4 as the sole expressed NOX in HAC.
The absence of NOX2 was conﬁrmed by real time RT-PCR experi-
ments (data not shown).
To conﬁrm NOX4 expression at the protein level in vivo, immu-
nohistochemical experiments were performed on human hip carti-
lage sections [Fig. 1(B)]. Results showed a gradual staining of NOX4
from the subchondral bone to the articular surface of the cartilage
[Fig.1(B) left panels] compared to the absenceof stainingwhenusing
the irrelevant antibody [Fig. 1(B) right panels]. Consistently, NOX4
proteins were also detected in ex vivo cultured HAC by Immunoblot
[Fig. 1(C)]. The high expression of NOX4 was conﬁrmed by confocal
microscopy, as showed by the staining of NOX4 in the perinuclear
area and next to the plasma membrane of HAC [Fig. 1(D)].
NOX4 activity is enhanced upon IL-1b stimulation in human
articular chondrocytes
We next addressed the functional impact of NOX by assessing
the production of ROS-induced by IL-1b in HAC. After 24 h of
stimulation by IL-1b, we observed a signiﬁcant increase of the
Fig. 1. NOX4 is the chondrocyte NADPH oxidase. (A) RNAwas extracted from HAC (n ¼ 3) and transcribed to cDNA as described in the Material and Methods section. Speciﬁc primers
were used to amplify cDNA encoding for NOX1 to NOX5 and p22phox (Table I Supplemental Data). Plasmids encoding NOX1 to NOX5 and P22phox were used as positive controls. (B)
Immunohistochemical detection of NOX4 on human cartilage sections by puriﬁed mAb8E9 (a and b) or irrelevant Ig (c and d). Photographed and printed to a ﬁnal magniﬁcation
of 500 for the upper pictures, and 1000 for the lowers. The arrow show NOX4 gradually expressed in human cartilage from the bone side to the articular surface. This result was
representative of n ¼ 3 human cartilage section. (C) NOX4 expression was assessed by immunoblot upon SDS-PAGE on 150 mg of protein from 1% (v/v) Triton X-100 extract obtained
from HAC (n ¼ 3 patients). Positive control, was obtained from C-20/A4 NOX4 cells. (D) HAC cultured ex vivo (passage 1) were ﬁxed with PFA, permeabilized and were respectively
stained with irrelevant IgM or the NOX4 speciﬁc 8E9 mAb antibody (red). The nucleus was coloured with Hoechst 33256 (blue). This result was representative of n ¼ 3 patients.
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optimum dose/response value at 2 ng/ml IL-1b (Supp. Fig. 1). Under
these conditions, the addition of the DPI, an inhibitor of NADPH
oxidase, led to a signiﬁcant inhibition of the IL-1b-stimulated ROS
production by HAC [Fig. 2(A)]. Moreover the use of GKT136901, a
pharmacological inhibitor of NOX4, had a similar effect. Further-
more, treatment with inhibitors of the NO synthase (L-NAME) and
of the mitochondrial respiratory chain (Azide and Rotenone), other
putative sources of ROS in HAC, did not affect the measured ROS
production detected by Amplex Red oxidation rate method [Supp.
Fig. 1(B)]. Together, these data suggest that NOX4 is the source of
ROS in HAC upon IL-1b stimulation. To conﬁrm this data, weassessed the impact of IL-1b on NOX4 and p22phox expression.
Interestingly, results showed a signiﬁcant increase of both NOX4
and p22phox as shown by immunoblot [Fig. 2(B)]. Hence, given the
constitutively active state of NOX4 in complex with p22phox, these
results suggest that the mechanism leading to the increase of ROS
production by IL-1b in HAC cells is mediated by an upregulation of
the amount of NOX4/p22phox complex.
NOX4 activity mediates MMP synthesis by chondrocytes
We have previously shown that ROS generated by NOX4 regu-
late the MMP-1 synthesis pathway in the IL-1b-stimulated C-20/A4
Fig. 2. NOX4 is a major source of ROS upon IL-1b stimulation in human articular
chondrocytes. (A) HAC were cultured in absence of FBS during 24 h and stimulated
with IL-1b for additional 24 h. Total H2O2 production was assessed by the Amplex Red
method by using 5  105 cells per well. NOX4 inhibitors (10 mM): DPI, GKT136901 or
DMSO (0.1%) were added in wells, 20 min before starting the experiment. Results are
expressed as the percentage increase vs non stimulated cells (NS) (þDMSO 0.1%) in
Relative Fluorescence Units (RFU) and were acquired every minute during 60 min.
Values represent the mean and 95% conﬁdence interval of three determinations (n ¼ 3
patients). (B) NOX4 and p22phox expression was assessed by immunoblot upon SDS-
PAGE on 150 mg of protein from 1% (v/v) Triton X-100 extract obtained from HAC
(representative of n ¼ 3 patients), stimulated or not (NS) with IL-1b for 24 h. Immu-
nodetection was performed by antibodies raised against NOX4 and p22phox or Actin as
loading control.
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Oxygenase-1 was potent to inhibit NOX4 activity and the subse-
quent MMP-1 release. We therefore assessed the impact of NOX
inhibition on IL-1b-induced MMP synthesis and release by primary
human chondrocytes. The results showed a strong increase of the
transcript level and of the quantity of MMP-1 andMMP-13 proteins
released in the HAC culture supernatant of after 24 h stimulation
with IL-1b [Fig. 3(D)]. Similarly, a strong induction of the tran-
scriptional level of MMP-1, MMP-13 and ADAMTs4 (respectively
300, 200 and 40 fold) was detected by RT-qPCR [Fig. 3(A), (B) and
(C)]. To determine the role of NOX4, we treated HAC cells with
CoPP for 24 h to induce the expression of HO-1 mRNA (Supp. Fig. 2)
or with DPI or GKT136901 to inhibit NOX4 activity. Interestingly,
induction of HO-1 expression dramatically decreased IL-1b-stim-
ulated MMP-1, MMP-13 and ADAMTS4 mRNA expression
[Fig. 3(A)e(C)]. In addition, despite non-statistically signiﬁcant re-
sults, we observed a similar tendency of the DPI and GKT136901
treatment to reduce the MMP-1 and MMP-13 transcriptional level.
This tendency was conﬁrmed at the protein level on HAC isolated
from 3 patients [Fig. 3(D)]. However, while ADAMTS4 transcription
was repressed by the other inhibitors, no effect of GKT136901 was
observed, suggesting that the aggrecanase is not regulated by NOX4
but rather by direct or indirect target of DPI and HO-1.
Together, our data demonstrate that IL-1b-mediatedMMP-1 and
MMP-13 synthesis and release in HAC are triggered by a production
of ROS. The data also strongly suggest a role of NOX4 in this pro-
catabolic pathway.
IL-1b induced ROS production is involved in inﬂammation
persistence
It is well established that inﬂammatory process plays a signiﬁ-
cant role in the OA pathology25. Especially, IL-1b acts in anautocrine/paracrine manner and induces its own neosynthesis by
chondrocyte, sustaining pro-catabolic pathways leading to cartilage
degradation26. We thus assessed whether the inhibition of NOX4
could impact the autocrine-mediated IL-1b synthesis. As assessed
by RT-qPCR, IL-1b treatment strongly induced IL-1b mRNA (about
4000 fold increase) [Fig. 4(A)]. Interestingly, the induction of HO-1
expression signiﬁcantly decreased IL-1b mRNA neosynthesis in
HAC. Despite non-statistically signiﬁcant results, the same ten-
dency was observed with DPI treatment. These results were
conﬁrmed at the protein level as assessed by ELISA assay in the
culture supernatant of C-20/A4 chondrocytes treated by CoPP or
with the antioxidant tiron [Fig. 4(B)]. Moreover, IL-1b-induced
p22phox transcription was also signiﬁcantly prevented by DPI and
by HO-1 induction. Similar tendency was observed with
GKT136901 treatment [Fig. 4(C)]. Collectively, the results demon-
strate for the ﬁrst time that the autocrine/paracrine loop mediated
by IL-1b in HAC is dependent on a production of ROS. Our data also
suggest that NOX4 and p22phox could be critical mediator involved
in this loop, sustaining in turn IL-1b neosynthesis and downstream
catabolic pathways in chondrocytes.
NOX4 is overexpressed in OA chondrocytes
As a whole, mechanistic data collected from HAC suggest that
NOX4 is a mediator of IL-1b-induced catabolic pathways. To further
conﬁrm the possible pathological implication of NOX4 in OA, we
decided to compare the level of NOX4 mRNA between chon-
drocytes isolated from parts of the hip cartilage of OA and of non OA
in a cohort of 14 patients. OA vs non OA criteria of the parts of
cartilages were evaluated by pathologists (data not shown). Inter-
estingly, we found a signiﬁcant upregulation of NOX4 mRNA in OA
chondrocytes (fold increase ¼ 13.98 ± 9.7; P ¼ 0.021 vs non OA
patients) [Fig. 5(A)]. Moreover, the basal production of ROS was
signiﬁcantly enhanced in OA chondrocytes (P ¼ 0.048) [Fig. 5(B)].
These clinical data are consistent with our previous observation on
IL-1b treated chondrocytes and support the idea that NOX4 may
participate to OA pathogenesis. Hence, we propose a mechanistic
model in which IL-1b mediates the expression of pro-catabolic
players e namely MMP-1 and MMP-13 e by a NOX4/p22phox
depend fashion [Fig. 6].
Discussion
We have previously shown the direct relation between NOX4
activity andMMP synthesis by the C-20/A4 chondrocytes cell line13.
The aim of the present study was to assess the functional relevance
of these in vitro observation in human pathological conditions,
namely in OA. Given the documented role of oxidative stress in
degenerative pathologies and especially in OA27, it is of importance
to note that only two recent studies describe the presence of NOX in
mice primary chondrocytes21,28. To our knowledge, this study
demonstrates for the ﬁrst time the presence of the NOX4 complex
(NOX4 and p22phox) in human articular chondrocyte. Moreover, at
the functional aspect, the increase of NOX4 expression observed
upon IL-1b treatment could mediate and sustain pro-catabolic
pathways. The relevance of these data in the pathophysiology of
osteoarthritis is supported by preliminary clinical data on 14
patients.
Potential sources of ROS have been identiﬁed in chondrocytes3.
Among them, uncoupled NO synthase, mitochondria respiratory
chain or NADPH oxidase could modulate chondrocyte behaviour
and extracellular matrix homeostasis. In fact, physiological role of
ROS in chondrocytes is not well understood. Indeed, according to
Martin et al. mitochondria dependent generation of ROS is neces-
sary to maintain glycolytic ATP production by chondrocytes29. ROS
Fig. 3. NOX4 activity regulates MMP synthesis. HAC (n ¼ 14 patients) were cultured in absence of FBS and induced or not for HO-1 expression by CoPP. After 24 h treatment with IL-
1b and NOX4 inhibitors (Tiron, DPI or GKT136901), total RNA was extracted from HAC for RT-qPCR analysis of MMP-1 (A), MMP-13 (B) and ADAMTs4 (C) (D) In parallel, supernatant
was recovered and 10 mg of proteins were loaded for MMP-1 and MMP-13 immunodetection by Western Blot. Experiments were performed on n ¼ 3 patients.
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Fig. 4. NOX4 activity sustains IL-1 autocrine/paracrine loop and p22phox upregulation.
(AeC) HAC were cultured in absence of FBS and induced or not for HO-1 expression by
CoPP. After 24 h treatment with IL-1b and NOX4 inhibitors (DPI and tiron), total RNA
was extracted from HAC (n ¼ 14 patients) for RT-qPCR analysis of IL-1b (A) and CYBA
(p22phox) (C). (B) C-20/A4 chondrocytes were treated or not with IL-1b and NOX4 in-
hibitors (tiron and CoPP). After 24 h, cell were washed 3 times to eliminated exogenous
IL-1b and medium was replaced. After additional 24 h neo-synthesized IL-1b was
assessed by ELISA method in the cell culture supernatant ¼ 3 patients.
Fig. 5. NOX4 is overexpressed in OA chondrocytes. (A) HAC were extracted and
cultured from damaged vs undamaged parts of articular cartilage (n ¼ 14 patients). At
passage 1, total RNA was extracted from HAC for RT-qPCR analysis of NOX4. Histogram
shows the comparison of NOX4 mRNA level between OA and non OA chondrocytes. (B)
In parallel, basal production of ROS was assessed by the Amplex Red method on 3
patients.
Fig. 6. The NOX4 pathway promote catabolism in human chondrocytes upon inﬂam-
matory condition. IL-1b treatment of HAC leads to an upregulation of p22phox mRNA,
stabilization of NOX4 at the protein level and an increased production of hydrogen
peroxide which acts as a crucial mediator of MMP-1, MMP-13 and ADAMTs4 expres-
sions themselves responsible for chondrocyte extracellular matrix catabolism. This
work also point out the redox regulation loop of p22phox and IL-1b suggesting that
NOX4 activity sustains catabolic pathways in HAC.
F. Rousset et al. / Osteoarthritis and Cartilage 23 (2015) 1972e19801978generated by NOX2 and NOX4 have also been suggested to act as
chondrogenesis mediator during the skeletal system develop-
ment21. Moreover, evidences show that ROS are involved in chon-
drocyte hypertrophic differentiation occurring in endochondral
ossiﬁcation30,31. NOX4 immunostaining on human cartilage slides
showed a clear gradient of NOX4 expression from the bone side to
the articular surface where oxygen is the most abundant. This
gradient is particularly relevant given catalytic function of NOX,
whose ﬁnal electron acceptor is molecular oxygen. Hence, it is
likely that in physiological conditions, especially during endo-
chondral ossiﬁcation, NOX4 could play a role in chondrogenesis or
in chondrocytes differentiation21,28.
However, in the inﬂammatory context, mimicked in our study
by the effects of IL-1b or in OA, ROS may play deleterious and pro-
catabolic functions in HAC. In the present study and upon IL-1b
stimulus, a role of NO synthase and mitochondria respiratory chain
was excluded [Supp. Fig. 1(B)]. Indeed, our data showed that ROSgenerated and NOX4-increased expression are critical mediators of
MMP-1, MMP-13 and ADAMTs4 synthesis and release by HAC.
Interestingly, the use of NOX inhibitors such as DPI, GKT136901 or
HO-1 was able to prevent this release.
It is well documented that IL-1b acts in an autocrine/paracrine
manner and induces its own neosynthesis by chondrocytes26. Our
results show indeed a clear induction of IL-1b mRNA upon IL-1b
stimulation of HAC. In addition, we bring in this study the ﬁrst
evidence that this loop is mediated by redox pathways in human
chondrocytes. In fact, both p22phox and NOX4 expression increase
upon IL-1b treatment probably contributing to sustain the pro-
duction of ROS and IL-1b neosynthesis. Interestingly, NOX
F. Rousset et al. / Osteoarthritis and Cartilage 23 (2015) 1972e1980 1979inhibitors (GKT, DPI and HO-1) also abolished the increase in
p22phox mRNA, disrupting this autocrine catabolic pathway. Such
transcriptional regulation of p22phox was also shown in EaHy926
endothelial cell line32. As a general observation, we notice that HO-
1 have a slightly better effect than NOX inhibitor on the expression
of MMP and on IL-1b neosynthesis. In fact, HO-1 is a multipotent
heat shock protein33. The multiple effects of HO-1 are all related to
the degradation of heme in bioactive compounds, namely bilirubin,
iron and carbon monoxide. As HO-1 has been shown to act as a
powerful anti-inﬂammatory agent in the context of OA34,35, it is
likely that the whole effects of HO-1 are not all related to NOX4
inhibition in chondrocytes, by example considering ADAMTS4
transcription.
As a whole, the present study strongly suggests a signiﬁcant
contribution of NOX4/p22phox the IL-1b-mediated expression of
MMP and IL-1b autocrine loop in human articular chondrocytes.
These results are supported by the signiﬁcant overexpression of
NOX4 mRNA and increased production of ROS observed in OA
compared to non OA condition in a cohort of 14 patients.
Nowadays, no available causal treatments are able to slow the
degenerative condition of articular cartilage during OA36. On the
other hand, many dietary supplements also displaying antioxidant
capacities have been assessed in OA37. Among them, the most
widely used compounds include proteoglycans such as chondroitin
or glucosamine sulfate and polyphenols such as resveratrol or
green tea extracts38. Some of these compounds seem to display
modest beneﬁts on the disease progression, however, antioxidant
therapies are often disappointing in vivo, mainly because of the
highly instable nature of ROS and their subsequent short half-life39.
Indeed, it would expect that scavengers are bioavailable in sufﬁ-
cient concentration and in very close proximity of the site of pro-
duction of the ROS. In this respect, we believe that pharmacological
inhibitors of NOX4 as well as HO-1 agonists might be a sound
strategy in the causal treatment of the disease. Further work,
especially using in vivo models, should be done to conﬁrm the
potential of this strategy.
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